Butantan Institute
36
3
4
24
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
2.8%
1 terminated/withdrawn out of 36 trials
96.0%
+9.5% vs industry average
42%
15 trials in Phase 3/4
8%
2 of 24 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (36)
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Role: collaborator
Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults
Role: lead
Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
Role: lead
Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.
Role: lead
Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)
Role: lead
Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .
Role: lead
Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine
Role: lead
Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine
Role: lead
Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA)
Role: lead
A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents
Role: lead
An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine
Role: lead
Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo
Role: lead
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
Role: lead
Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals
Role: lead
Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine
Role: lead
Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil
Role: lead
Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine
Role: lead
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza
Role: lead
Efficacy, Immunogenicity and Safety of Inactivated Vaccine (Coronavac) Against SARS-COV2 in Children and Adolescents
Role: collaborator
Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity
Role: collaborator